Drug Could Offer New Option Against Lupus
THURSDAY, Dec. 19, 2019 (HealthDay News) — People suffering from the autoimmune disease lupus might soon have a new drug to turn to, a clinical trial suggests. Anifrolumab is a lab-created antibody that blocks type 1 interferon, a biochemical that activates an immune response in humans, explained lead researcher EricContinue Reading